Market Place
Sourcing Support
FDA declines to approve Zealand Pharma`s bowel disease drug
20 Dec 2024 //
REUTERS
Zealand Pharma Enrolls 1st Participant in Phase 2b ZUPREME-1 Trial
10 Dec 2024 //
GLOBENEWSWIRE
Zealand Pharma to Attend Jefferies London Healthcare Conf.
13 Nov 2024 //
GLOBENEWSWIRE
Zeal& Pharma Share Transactions by Management & Associated Persons
11 Nov 2024 //
GLOBENEWSWIRE
Zealand Pharma Starts Phase 2b Trial for Obesity Drug in Q4
07 Nov 2024 //
REUTERS
Zealand Pharma Announces Financial Results for 9 Months of 2024
07 Nov 2024 //
GLOBENEWSWIRE
Zealand Pharma to Present Q3 2024 Financial Results on Nov 7
01 Nov 2024 //
GLOBENEWSWIRE
Zealand Pharma Provides Update On Dasiglucagon In CHI
09 Oct 2024 //
GLOBENEWSWIRE
FDA declines to approve Zealand drug for low blood sugar in infants
09 Oct 2024 //
REUTERS
Zealand And Boehringer Win FDA Breakthrough For Fatty Liver
07 Oct 2024 //
REUTERS
Zealand Pharma Reports Total Shares & Voting Rights As Of Sept 30
30 Sep 2024 //
GLOBENEWSWIRE
Zealand Pharma To Attend 2024 Cantor Global Healthcare Conference
13 Sep 2024 //
GLOBENEWSWIRE
Zealand Pharma Increases Share Capital From Employee Warrants
12 Sep 2024 //
GLOBENEWSWIRE
Weight-loss market to see 16 new drugs by 2029, report estimates
11 Sep 2024 //
EXPRESSPHARMA
Zealand Pharma`s GLP-1/GLP-2 Agonist Achieves 8.3% Weight Loss
10 Sep 2024 //
FIERCE BIOTECH
Zealand Pharma Announces Positive Topline Results
09 Sep 2024 //
GLOBENEWSWIRE
Total number of shares and voting rights in Zealand Pharma on August 30, 2024
30 Aug 2024 //
GLOBENEWSWIRE
Zealand Pharma Reports Transactions In Shares By Management
30 Aug 2024 //
GLOBENEWSWIRE
Zealand Pharma Increases Share Capital From Employee Warrants
22 Aug 2024 //
GLOBENEWSWIRE
Zealand Pharma major shareholder announcement: Bank of America Corporation
16 Aug 2024 //
GLOBENEWSWIRE
Zealand Pharma Announces Financial Results for the First Half of 2024
15 Aug 2024 //
GLOBENEWSWIRE
Zealand Pharma seeks big pharma partners for obesity drug candidate
15 Aug 2024 //
REUTERS
Zealand Pharma To Present H1 2024 Results On August 15
12 Aug 2024 //
GLOBENEWSWIRE
Zealand Pharma Appoints Eric Cox as Chief Commercial Officer
29 Jul 2024 //
GLOBENEWSWIRE
Pharma’s Obsession With Obesity On Rise
01 Jul 2024 //
BIOSPECTRUM ASIA
Total number of shares and voting rights in Zealand Pharma at June 28, 2024
28 Jun 2024 //
GLOBENEWSWIRE
Zealand Pharma major shareholder announcement: Van Herk Investments
28 Jun 2024 //
GLOBENEWSWIRE
Zealand Pharma completes registration of capital increase
28 Jun 2024 //
GLOBENEWSWIRE
ICPO Theranostics Virtual Summit on Cancer Care, Nov 14-15, 2024
27 Jun 2024 //
GLOBENEWSWIRE
Zealand Launches Equity Offering Raising USD 900 Million / DKK 6.257 Billion
25 Jun 2024 //
GLOBENEWSWIRE
Zealand announces completion of an upsized equity offering of 8.35 million
25 Jun 2024 //
GLOBENEWSWIRE
Zealand Pharma Reports Positive Phase 1b Results For Petrelintide Trial
20 Jun 2024 //
GLOBENEWSWIRE
Zealand Increases its Share Capital of Exercise of Employee Warrants
13 Jun 2024 //
GLOBENEWSWIRE
Zealand: Boehringer`s Survodutide Cut Fibrosis, No MASH Worsening
07 Jun 2024 //
GLOBENEWSWIRE
Zealand: Boehringer To Present Positive Survodutide MASH Trial At EASL
06 Jun 2024 //
GLOBENEWSWIRE
Zealand`s Dasiglucagon Severe Hypoglycemia Med Gets CHMP Nod
31 May 2024 //
GLOBENEWSWIRE
Zealand Pharma At June 2024 Healthcare Investor Conferences
29 May 2024 //
GLOBENEWSWIRE
Zealand Pharma major shareholder announcement: Polar Capital
29 May 2024 //
GLOBENEWSWIRE
Zealand`s dapiglutide shows little weight loss at lowest doses
25 May 2024 //
FIERCE BIOTECH
Zealand Dapiglutide Topline Results: Glp-1/2 Dual Agonist Dream Trial
23 May 2024 //
GLOBENEWSWIRE
Zealand Pharma Announces Financial Results for the First Quarter of 2024
16 May 2024 //
GLOBENEWSWIRE
Monte Rosa’s $100M offering; Alexion to hand back preclinical program to Zealand
16 May 2024 //
ENDPTS
Zealand Pharma Insider Share Transactions Disclosure
12 May 2024 //
GLOBENEWSWIRE
Zealand Pharma Q1 2024 Results Call On May 16
09 May 2024 //
GLOBENEWSWIRE
Zealand Partners with Benchling to Advance R&D of Engineered Peptide Medicines
24 Apr 2024 //
PR NEWSWIRE
Zealand Launches 2024 LTI Programs For Board, Management, Employees
19 Apr 2024 //
GLOBENEWSWIRE
Zealand Pharma Director/Management Transactions Reported
19 Apr 2024 //
GLOBENEWSWIRE
Correction to Company announcement - No. 23 / 2024
19 Apr 2024 //
GLOBENEWSWIRE
Total number of shares and voting rights in Zealand Pharma at March 31, 2024
31 Mar 2024 //
GLOBENEWSWIRE
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of EW
26 Mar 2024 //
GLOBENEWSWIRE
Transactions in Zealand Pharma shares and/or related securities
26 Mar 2024 //
GLOBENEWSWIRE
Zealand Pharma major shareholder announcement: Van Herk Investments
21 Mar 2024 //
GLOBENEWSWIRE
Zealand Pharma`s Annual General Meeting 2024
20 Mar 2024 //
GLOBENEWSWIRE
Transactions in Zealand shares &/or related securities by persons discharging
19 Mar 2024 //
GLOBENEWSWIRE
Zealand Pharma major shareholder announcement: Polar Capital
19 Mar 2024 //
GLOBENEWSWIRE
New Employee Elected Directors to the Board of Zealand Pharma A/S
13 Mar 2024 //
GLOBENEWSWIRE
Transactions in Zealand Pharma shares and/or related securities
08 Mar 2024 //
GLOBENEWSWIRE
Zealand Pharma Increases its Share Capital
05 Mar 2024 //
GLOBENEWSWIRE
Transactions in Zealand Pharma shares and/or related securities
05 Mar 2024 //
GLOBENEWSWIRE
Zealand Pharma to Participate in TD Cowen™s 44th Annual Health Care Conference
01 Mar 2024 //
GLOBENEWSWIRE
